43 studies found for:    prostate cancer, psma, treat
Show Display Options
Rank Status Study
1 Completed Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel
Condition: Prostate Cancer
Intervention: Biological: rsPSMA protein plus Alhydrogel® vaccine
2 Recruiting Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)
Condition: Prostate Cancer
Interventions: Biological: engineered autologous T cells;   Drug: cyclophosphamide
3 Not yet recruiting Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management
Condition: Prostate Cancers
Intervention: Drug: 68Ga-(HBED-CC)-PSMA
4 Not yet recruiting 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
Conditions: Prostate Adenocarcinoma;   PSA Failure;   Recurrent Prostate Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx)-HBED-CC;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
5 Completed An Open-label Treatment Extension of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
Condition: Prostate Cancer
Intervention: Drug: PSMA ADC
6 Recruiting 68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: 68Ga-PSMA
7 Active, not recruiting
Has Results
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
Condition: Prostate Cancer
Interventions: Biological: Peptide Vaccine;   Drug: Poly IC-LC
8 Recruiting Prospective Evaluation of 68-Ga-prostate Specific Membrane Antigen (PSMA)-Positron Emission Tomograph (PET) and Early Prostatic Specific Antigen (PSA) Kinetics During Salvage Radiotherapy for Personalizing the Management of Men With Relapse of Prostate Cancer After Radical Prostatectomy
Condition: Relapsed Prostate Cancer
Intervention: Radiation: External radiation therapy
9 Recruiting Integrated 18F-labelled PSMA Project
Condition: Prostate Cancer
Intervention: Drug: 18F-DCFPyL
10 Completed Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: PSA prostate cancer vaccine;   Biological: recombinant interleukin-12
11 Unknown  Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: PSA prostate cancer vaccine;   Biological: therapeutic autologous dendritic cells
12 Recruiting J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts
Condition: Prostate Cancer
Intervention: Drug: huJ591
13 Withdrawn Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.
Condition: Prostate Cancer
Intervention: Drug: Dendritic cell immunotherapy
14 Recruiting Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Drug: Ga-68 labeled HBED-CC PSMA PET imaging
15 Not yet recruiting PET/MRI in Patients With Suspected Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: 68Ga- PSMA-HBED-CC;   Device: Biograph mMR, Siemens
16 Recruiting Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
Conditions: Cancer of Prostate;   Cancer of the Prostate;   Neoplasms, Prostate;   Neoplasms, Prostatic;   Prostate Cancer;   Prostate Neoplasms;   Prostatic Cancer
Interventions: Biological: androgen ablation (AA);   Biological: DC1 vaccine
17 Withdrawn Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer
Condition: Prostate Cancer.
Intervention: Drug: G-202
18 Completed Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: PSMA ADC
19 Completed Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: PSMA ADC
20 Unknown  Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: 18F-DCFBC

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years